COVID-19 Project Team: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 16: | Line 16: | ||
*[[User:Rija Gul|Rija Gul, M.D.]] | *[[User:Rija Gul|Rija Gul, M.D.]] | ||
*[[User:Rinky Agnes Botleroo|Rinky Agnes Botleroo, M.D.]] | *[[User:Rinky Agnes Botleroo|Rinky Agnes Botleroo, M.D.]] | ||
*[[User:Roukoz Abou Karam| | *[[User:Roukoz Abou Karam|Roukoz Abou Karam, M.D.]] | ||
*[[User:Hudakarman|Huda A. Karman M.D., M.P.H., M.S.]] | *[[User:Hudakarman|Huda A. Karman M.D., M.P.H., M.S.]] | ||
*Sara Haddadi | *Sara Haddadi |
Revision as of 02:57, 8 June 2020
COVID-19 Project |
---|
Introduction |
Team |
Meetings' Summary |
Topics |
Ongoing Clinical Trials |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Meet The Team
- Associate Editor(s)-in-Chief:
- Aisha Adigun, M.D.
- Bosky Soni, M.D.
- Gurmandeep Singh Sandhu
- Mandana Safakhah
- Neepa Shah, M.B.B.S.
- Oluwabusola Adogba
- Rija Gul, M.D.
- Rinky Agnes Botleroo, M.D.
- Roukoz Abou Karam, M.D.
- Huda A. Karman M.D., M.P.H., M.S.
- Sara Haddadi
- Sara Mohsin, M.B.B.S.
- Sogand Goudarzi, M.D.
- Zaida Obeidat